Article Information
History
- March 29, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Jonas Andreas Schmid1,+,
- Yasmin Festl2,+,
- Yannik Severin2,+,
- Ulrike Bacher3,
- Marie-Noëlle Kronig4,
- Berend Snijder2,*,$ and
- Thomas Pabst4,$
- 1Faculty of Medicine University of Bern, Bern, Switzerland
- 2Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, Zürich, Switzerland
- 3Department of Hematology; Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
- 4Department of Medical Oncology; Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
- ↵*Correspondence: Berend Snijder, Prof. Dr.; Assistant Professor; Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, 8093 Zürich, Switzerland; snijder{at}imsb.biol.ethz.ch, +41446337149
Posted March 29, 2023.
Efficacy and feasibility of Pharmacoscopy-guided treatment for acute myeloid leukemia patients that exhausted all registered therapeutic options
